Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21
11 Febbraio 2025 - 12:00PM
Business Wire
As the preterm birth rate remains at an all-time high,
continuing education for providers of neonatal intensive care is
critical
Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of
physician services, is pleased to announce NEO: The Conference for
Neonatology, a premier educational event dedicated to advancing the
field of neonatology. The conference will be held Feb. 19-21 in Las
Vegas, Nevada, and will bring together neonatologists,
pediatricians, advanced practitioners and allied health
professionals from around the globe.
As a trusted provider of neonatology services for more than 45
years, Pediatrix cares for nearly a quarter of the infants born in
the United States that require intensive care.
The March of Dimes’ 2024 Report Card, released in November,
reported that the nation’s preterm birth rate remains historically
high at 10.4%, with 370,000 babies born prematurely in 2023. In
2022, the rate was 10.5%. The U.S. earned a D+ for the third
consecutive year, remaining the worst grade in the report’s
history.
“These findings emphasize the need for continuous innovation in
the field of neonatal-perinatal medicine,” said Timothy Biela,
M.D., neonatologist at Pediatrix Neonatology of San Antonio and
director of the NEO conference. “We are proud to lead research
efforts and provide continuing education opportunities not only for
our affiliated clinicians, but for all providers of this highly
specialized care. Our hope is to improve outcomes for our youngest
and most vulnerable patients.”
About the Conference
Now in its 46th year, the NEO conference addresses the latest
advancements, research and best practices in neonatology. The
meeting aims to provide a platform for knowledge exchange,
professional development and collaboration among health care
professionals dedicated to the care of newborns.
The comprehensive program includes:
- Plenary sessions on cutting-edge research and clinical
practices
- Interactive workshops and hands-on training sessions
- Panel discussions with industry experts and thought
leaders
- Networking opportunities with peers and leaders in
neonatology
- Exhibits showcasing the latest technologies and products in
neonatal care
Keynote Speakers
The NEO conference will feature an impressive lineup of keynote
speakers, including renowned experts in the field of neonatology.
Among the distinguished speakers are:
- Dan Ellsbury, M.D., Director of Quality and Safety for
Neonatology, the Pediatrix Center for Research, Education, Quality
and Safety (CREQS)
- Elizabeth Foglia, M.D., MSCE, Associate Professor of
Pediatrics, University of Pennsylvania Perelman School of Medicine
| Children’s Hospital of Philadelphia
- Haresh Kirpalani, M.D., Professor of Pediatrics, University of
Pennsylvania Perelman School of Medicine
- Josef Neu, M.D., Professor of Pediatrics, University of Florida
College of Medicine
- Noelle Younge, M.D., MHS, Jean and George W. Brumley, Jr.,
M.D., Assistant Professor of Pediatrics, Duke University School of
Medicine
- Robert Ursprung, M.D., MMSc, Director of Quality and Safety for
Neonatology, the Pediatrix CREQS
These thought leaders will share their insights on
groundbreaking research, innovative treatments and emerging trends
in neonatal care.
Legends of Neonatology
Established in 2007, the Legends of Neonatology award honors
remarkable individuals whose clinical contributions have helped
forge new ground in neonatal medicine. This year’s recipient is
David K. Stevenson, M.D., Harold K. Faber Professor of Pediatrics,
Senior Associate Dean for Maternal and Child Health at the Stanford
University School of Medicine and Principal Investigator of the
Prematurity Research Center. Over the span of four decades, Dr.
Stevenson has been at the forefront of research, professional
education and clinical care in neonatology. He has made pioneering
contributions to neonatology and pediatrics through extensive
research in bilirubin biochemistry, heme oxygenase biology and
neonatal jaundice. His work has led to new technologies and
standards of care for the treatment of neonatal jaundice.
Accredited Continuing Education
Participants attending the NEO conference will have the
opportunity to earn accredited continuing education credits. The
Pediatrix CREQS is accredited by:
- The Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians, designating
this live activity for a maximum of 20.25 AMA PRA Category 1
Credits™.
- The American Nurses Credentialing Center’s Commission on
Accreditation as a provider of nursing continuing professional
development, designating this live activity for a maximum of 20.25
nursing contact hour(s).
About Pediatrix Medical Group
Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider
of physician services. Pediatrix-affiliated clinicians are
committed to providing coordinated, compassionate and clinically
excellent services to women, babies and children across the
continuum of care, both in hospital settings and office-based
practices. Specialties include obstetrics, maternal-fetal medicine
and neonatology. The group’s high-quality, evidence-based care is
bolstered by significant investments in research, education,
quality improvement and safety initiatives. The physician-led
company was founded in 1979 as a single neonatology practice and
today provides its highly specialized and often critical care
services through approximately 4,400 affiliated physicians and
other clinicians. To learn more about Pediatrix, visit
www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and
the Pediatrix blog. Investment information can be found at
www.pediatrix.com/investors.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250211765616/en/
For media inquiries, please contact: Jennifer Gutierrez,
Corporate Communications jennifer.gutierrez@pediatrix.com
954.384.0175 ext. 5684
Grafico Azioni Pediatrix Medical (NYSE:MD)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Pediatrix Medical (NYSE:MD)
Storico
Da Feb 2024 a Feb 2025